Real‐World Weight‐Loss Outcomes in Weight‐Reduced Patients Treated With Tirzepatide
Tirzepatide produced meaningful weight loss across groups but outcomes varied based on weight-reduction status, T2D status, and prior response to semaglutide.
Authors
- Alice Zhao (ORCID: https://orcid.org/0000-0001-5845-8071)
- Alpana P. Shukla (ORCID: https://orcid.org/0000-0002-4763-2350)
- Sarah R. Barenbaum (ORCID: https://orcid.org/0000-0001-8453-9430)
- Zoe Verzani
- Ariel F. Gonzalez
Institutions
- Beth Israel Deaconess Medical Center (US)
- Cornell University (US)
Publication Details
- Journal
- Obesity
- Published
- 2026-03-28
- DOI
- https://doi.org/10.1002/oby.70179
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00